Company Analysis

Precision BioSciences, Inc. (DTIL)

Nasdaq: DTIL · Biological Products, (No Diagnostic Substances) · Durham, NC · filing with the SEC since 2006
Grade4.7
◀ Past 4.8● Present 4.6▶ Future 4.7
1 est.

Who runs Precision BioSciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Amoroso Michael
President and CEO. First filing Oct 2021, latest Jun 3, 2026, 11 filings in all.
Officers reporting now
7
of 12 people with a filing in the last fifteen months
Directors reporting now
5
26 people on the record since 2019
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Scimeca DarioChief Legal OfficerJun 2019Nov 12, 20263 · $100,000
Tanna Naresh HareshChief Financial OfficerAug 2026Aug 3, 2026none
Gorsuch Cassandra LouiseChief Scientific OfficerAug 2026Aug 3, 2026none
Burris Mei Zhang LuChielf Accounting OfficerAug 2026Aug 3, 2026none
Amoroso MichaelPresident and CEOOct 2021Jun 3, 20262 · $200,000
Kelly John AlexanderChief Financial OfficerJan 2021Jun 3, 20262 · $100,000
Smith J. JeffersonChief Research OfficerMar 2019Jun 3, 20262 · $100,000
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Frankel StanleydirectorApr 2021Sep 30, 2026none
Brown MelindadirectorMay 2022Sep 29, 2026none
Germano Geno JdirectorMar 2020Sep 29, 2026none
Buehler KevindirectorNov 2019Jun 5, 2026none
Pire Shari LisadirectorNov 2021Jun 5, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton DTIL · research, not advice